These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17196369)
1. Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children. Rosso R; Di Biagio A; Dentone C; Bassetti M; Viscoli C; Parodi A; De Maria A Int J Antimicrob Agents; 2007 Feb; 29(2):228-30. PubMed ID: 17196369 [No Abstract] [Full Text] [Related]
10. Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis. Boyd MA; Burger DM; Phanuphak P; Cooper DA AIDS; 2006 Apr; 20(7):1083-5. PubMed ID: 16603870 [No Abstract] [Full Text] [Related]
11. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. Martínez E; Arnaiz JA; Podzamczer D; Dalmau D; Ribera E; Domingo P; Knobel H; Riera M; Pedrol E; Force L; Llibre JM; Segura F; Richart C; Cortés C; Javaloyas M; Aranda M; Cruceta A; de Lazzari E; Gatell JM; N Engl J Med; 2003 Sep; 349(11):1036-46. PubMed ID: 12968087 [TBL] [Abstract][Full Text] [Related]
12. DMP 266 and indinavir combination. AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845 [No Abstract] [Full Text] [Related]
13. Clinical history of efavirenz. Ruiz N Int J Clin Pract Suppl; 1999 Jun; 103():3-7. PubMed ID: 10622035 [TBL] [Abstract][Full Text] [Related]
14. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275 [TBL] [Abstract][Full Text] [Related]
16. Combination study for children. Vazquez E Posit Aware; 1998; 9(1):15. PubMed ID: 11364991 [TBL] [Abstract][Full Text] [Related]
17. Anti-HIV agents. Efavirenz makes its mark in AIDS. TreatmentUpdate; 2002 Aug; 14(6):6-7. PubMed ID: 12238453 [No Abstract] [Full Text] [Related]
18. Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy. Saah AJ; Haas DW; DiNubile MJ; Chen J; Holder DJ; Rhodes RR; Shivaprakash M; Bakshi KK; Danovich RM; Graham DJ; Condra JH J Infect Dis; 2003 Apr; 187(7):1157-62. PubMed ID: 12660932 [TBL] [Abstract][Full Text] [Related]
19. Moving forward: a treatment overview from the 12th World AIDS Conference. Agosto M Newsline People AIDS Coalit N Y; 1998 Sep; ():6-11. PubMed ID: 11367497 [TBL] [Abstract][Full Text] [Related]
20. Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz. Viganò A; Brambilla P; Cafarelli L; Giacomet V; Borgonovo S; Zamproni I; Zuccotti G; Mora S Antivir Ther; 2007; 12(3):297-302. PubMed ID: 17591019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]